# Adaptimmune Therapeutics PLC: Form 10-Q/A for the period ended Mar 31, 2020

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: 10-Q/A
- Filed: 2020-05-28
- Accepted by EDGAR: May 28, 2020, 16:37 ET
- Period: 2020-03-31
- Accession: 0001104659-20-067101
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000110465920067101/tm2021217-1_10qa.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000110465920067101/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000110465920067101/tm2021217-1_10qa.htm

Filed May 28, 2020.
Source: SEC EDGAR, the filing index for accession 0001104659-20-067101. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.
